Synthesis, antiviral activity and structure–activity relationship of 1-(1-aryl-4,5-dihydro-1H-imidazoline)-3-chlorosulfonylureas and products of their cyclization

References

• Cao T, Xing Y, Yang Y, Mei H. Correlation between matrix metalloproteinase expression and activation of the focal adhesion kinase signaling pathway in herpes stromal keratitis. Exp Ther Med 2014;7:280–6
   PubMed Web of Science ®Google Scholar
• Bove D, Lupoli A, Caccavale S, et al. Dermatological and immunological conditions due to nerve lesions. Funct Neurol 2013;28:83–91
   PubMedGoogle Scholar
• Steiner I, Benninger F. Update on Herpes Virus infections of the nervous system. Curr Neurol Neurosci Rep 2013;13:414–20
   PubMed Web of Science ®Google Scholar
• Kolokotronis A, Doumas S. Herpes simplex virus infection, with particular reference to the progression and complications of primary herpetic gingivostomatitis. Clin Microbiol Infect 2006;12:202–11
   PubMed Web of Science ®Google Scholar
• He DX, Tam SC. Trichosanthin affects HSV-1 replication in Hep-2 cells. Biochem Biophys Res Commun 2010;402:670–5
   PubMed Web of Science ®Google Scholar
• Ju HQ, Xiang YF, Xin BJ, et al. Synthesis and in vitro anti-HSV-1 activity of a novel Hsp90 inhibitor BJ-B11. Bioorg Med Chem Lett 2011;21:1675–7
   PubMed Web of Science ®Google Scholar
• Alekseev O, Donovan K, Azizkhan-Clifford J. Inhibition of ataxia telangiectasia mutated (ATM) kinase suppresses Herpes Simplex virus type 1 (HSV-1) keratitis. J Invest Ophthalmol Vis Sci 2014;55:706–15
   PubMed Web of Science ®Google Scholar
• Yajima T, Knowlton KU. Viral myocarditis: from the perspective of the virus. Circulation 2009;119:2615–24
   PubMed Web of Science ®Google Scholar
• Kemball CC, Harkins S, Whitmire JK, et al. Coxsackievirus B3 inhibits antigen presentation in vivo, exerting a profound and selective effect on the MHC class I pathway. PLoS Pathog 2009;5:e1000618
   Google Scholar
• Tang S, Kong L, Li Y, et al. Novel N-benzenesulfonyl sophocarpinol derivatives as coxsackie B virus inhibitors. ACS Med Chem Lett 2015;6:183–6
   PubMed Web of Science ®Google Scholar
• Yin D, Li J, Lei X, et al. Antiviral activity of total flavonoid extracts from Selaginella moellendorffii hieron against Coxsackie Virus B3 in vitro and in vivo. Evid Based Complement Alternat Med 2014;2014:950817
   PubMed Web of Science ®Google Scholar
• Albulescu L, Strating JR, Thibaut HJ, et al. Broad-range inhibition of enterovirus replication by OSW-1, a natural compound targeting OSBP. Antiviral Res 2015;117:110–14
   PubMed Web of Science ®Google Scholar
• Strating JR, van der Linden L, Albulescu L, et al. Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding protein. Cell Rep 2015;10:600–15
   PubMed Web of Science ®Google Scholar
• Rządkowska M, Szacoń E, Kaczor AA, et al. 407102 (Polish patent claim)
   Google Scholar
• Szacoń E, Rządkowska M, Rajtar B, et al. 407103 (Polish patent claim)
   Google Scholar
• Saczewski F, Debowski T, Szmigiel J. Synthesis and transformations of 2-amino-1(4,5-dihydro-1H-imidazol-2-yl)benzimidazoles. A route to 2,3-dihydrobenzo[4,5]-imidazo[1,2-a][1,3,5]triazine ring system. Heterocycles 1998;48:1879–85
   Web of Science ®Google Scholar
• Saczewski F, Kuchnio A, Samsel M, et al. Synthesis of novel aryl(heteroaryl)sulfonyl of possible biological interest. Molecules 2010;15:1113–26
   PubMed Web of Science ®Google Scholar
• LigPrep, Version 2.4: Schrödinger, LLC, New York; 2010
   Google Scholar
• Epik, Version 2.1: Schrödinger, LLC, New York; 2010
   Google Scholar
• Spartan 10. Wavefunction, Inc., Irvine, CA, USA. Available from: www.wavefun.com
   Google Scholar
• Pedretti A, Villa L, Vistoli G. VEGA – an open platform to develop chemo-bio-informatic applications, using plug-in architecture and script programming. J Comput Aided Mol Des 2004;18:167–73
   PubMed Web of Science ®Google Scholar
• Discovery Studio 3.1, Accelrys
   Google Scholar
• Rządkowska M, Szacoń E, Kaczor AA, et al. Synthesis, pharmacological activity and molecular modeling of 1-aryl-7-hydroxy-2,3-dihydroimidazo[1,2-a]pyrimidine-5(1H)-ones and their 6-substituted derivatives. Med Chem 2014;10:460–75
   PubMed Web of Science ®Google Scholar
• Rządkowska M, Szacoń E, Kaczor AA, et al. Synthesis, central nervous system activity, and structure–activity relationship of 1-aryl-6-benzyl-7-hydroxy-2,3-dihydroimidazo[1,2-a]pyrimidine-5(1H)-ones. Med Chem Res 2014;23:4221–37
   PubMed Web of Science ®Google Scholar
• Szacoń E, Rządkowska M, Kaczor AA, et al. Synthesis, central nervous system activity and structure-activity relationship of N-substituted derivatives of 1-arylimidazolidyn-2-ylideneurea and products of their cyclization. J Enzyme Inhib Med Chem 2015. [Epub ahead of print]. doi:10.3109/14756366.2014.965699
   Web of Science ®Google Scholar
• Rządkowska M, Szacoń E, Kaczor AA, et al. Synthesis and antiviral activity of 1-(1,3-disubstitutedimidazolidyn-2-ylidene)-3-ethoxycarbonylmethylurea derivatives. J Enzyme Inhib Med Chem 2015. [Epub ahead of print]. doi:10.3109/14756366.2015.1022172
   Web of Science ®Google Scholar
• Osiris Property Explorer. Available from: http://www.organic-chemistry.org/prog/peo/logS.html
   Google Scholar
• http://www.arguslab.com/arguslab.com/ArgusLab.html [last accessed 20 Dec 2014]
   Google Scholar
• Reed LJ, Muench MA. A simple method of estimating fifty percent end points. Am J Hyg 1938;27:493–7
   Google Scholar
• Takenouchi T, Munekata E. Amyloid beta-peptide-induced inhibition of MTT reduction in PC12h and C1300 neuroblastoma cells: effect of nitroprusside. Peptides 1998;19:365–72
   PubMed Web of Science ®Google Scholar
• Lee SK, Chang GS, Lee IH, et al. The PreADME:pc-based program for batch prediction of adme properties, EuroQSAR 2004, 9.5-10, Istanbul, Turkey
   Google Scholar
• Walters WP. Going further than Lipinski's rule in drug design. Expert Opin Drug Discov 2012;7:99–107
   PubMed Web of Science ®Google Scholar
• Oprea TI. Property distribution of drug-related chemical databases. J Comput Aid Mol Des 2000;14:251–64
   PubMed Web of Science ®Google Scholar
• Brown RD. Tools for designing diverse, drug like, cost-effective combinatorial libraries. In: Ghose A, Viswanadhan V, eds. Combinatorial library design and evaluation. New York: Marcel Dekker Inc.; 2001
   Google Scholar